Thursday, September 18, 2025
HomePublic Health

Public Health

Public Health

Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine

Life Sciences Times - 0
Public Health

Moderna Announces FDA Advisory Committee Unanimously Votes in Support of Emergency Use for a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.

Life Sciences Times - 0
Public Health

Henry Schein CEO Stanley M. Bergman Issues Statement Supporting Primary-Care Physician Access to COVID-19 Vaccines

Life Sciences Times - 0
Pharma

COVID-19: Cytokine Storm and Coagulopathy Markers Controlled With Nichi Glucan Variants; The First of Its Kind Report in a Clinical Study

Life Sciences Times - 0
Public Health

AZD7442 Request for Emergency Use Authorization for COVID-19 Prophylaxis Filed in US

Life Sciences Times - 0
Public Health

Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age

Life Sciences Times - 0
Public Health

AstraZeneca COVID-19 and RSV presentations at IDWeek 2021 will showcase scientific progress in infectious diseases

Life Sciences Times - 0
Public Health

R-Zero Arc Lands Bronze in 2021 International Design Excellence Awards

Life Sciences Times - 0
Public Health

Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine Booster

Life Sciences Times - 0
Pharma

Veklury® (Remdesivir) Significantly Reduced Risk of Hospitalization in High-Risk Patients with COVID-19

Life Sciences Times - 0
Public Health

Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries

Life Sciences Times - 0
Public Health

Nomi Health Pays Off Medical Debt Valued at More than $225 Million for Americans Burdened by Surprise Billing and High Healthcare Costs

Life Sciences Times - 0
1...222324...34Page 23 of 34

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv